Dörffel W - Search Results

1

Importance of F18-fluorodeoxy-D-2-glucose positron emission tomography (FDG-PET) for staging and therapy control of Hodgkin's lymphoma in childhood and adolescence - consequences for the GPOH-HD 2003 protocol.

Körholz D, Kluge R, Wickmann L, Hirsch W, Lüders H, Lotz I, Dannenberg C, Hasenclever D, Dörffel W, Sabri O. Körholz D, et al. Among authors: dorffel w. Onkologie. 2003 Oct;26(5):489-93. doi: 10.1159/000072984. Onkologie. 2003. PMID: 14605468

2

The concept of the GPOH-HD 2003 therapy study for pediatric Hodgkin's disease: evolution in the tradition of the DAL/GPOH studies.

Körholz D, Claviez A, Hasenclever D, Kluge R, Hirsch W, Kamprad F, Dörffel W, Wickmann L, Papsdorf K, Dieckmann K, Kahn T, Mauz-Körholz C, Dannenberg C, Pötter R, Brosteanu O, Schellong G, Sabri O. Körholz D, et al. Among authors: dorffel w. Klin Padiatr. 2004 May-Jun;216(3):150-6. doi: 10.1055/s-2004-822627. Klin Padiatr. 2004. PMID: 15175959

3

Procarbazine-free OEPA-COPDAC chemotherapy in boys and standard OPPA-COPP in girls have comparable effectiveness in pediatric Hodgkin's lymphoma: the GPOH-HD-2002 study.

Mauz-Körholz C, Hasenclever D, Dörffel W, Ruschke K, Pelz T, Voigt A, Stiefel M, Winkler M, Vilser C, Dieckmann K, Karlén J, Bergsträsser E, Fosså A, Mann G, Hummel M, Klapper W, Stein H, Vordermark D, Kluge R, Körholz D. Mauz-Körholz C, et al. Among authors: dorffel w. J Clin Oncol. 2010 Aug 10;28(23):3680-6. doi: 10.1200/JCO.2009.26.9381. Epub 2010 Jul 12. J Clin Oncol. 2010. PMID: 20625128

4

Response-adapted radiotherapy in the treatment of pediatric Hodgkin's disease: an interim report at 5 years of the German GPOH-HD 95 trial.

Rühl U, Albrecht M, Dieckmann K, Lüders H, Marciniak H, Schellenberg D, Wickmann L, Dörffel W. Rühl U, et al. Among authors: dorffel w. Int J Radiat Oncol Biol Phys. 2001 Dec 1;51(5):1209-18. doi: 10.1016/s0360-3016(01)01798-9. Int J Radiat Oncol Biol Phys. 2001. PMID: 11728679 Clinical Trial.

5

[18-FDG-PET-findings in children and adolescents with Hodgkin's disease: retrospective evaluation of the correlation to other imaging procedures in initial staging and to the predictive value of follow up examinations].

Wickmann L, Lüders H, Dörffel W. Wickmann L, et al. Among authors: dorffel w. Klin Padiatr. 2003 May-Jun;215(3):146-50. doi: 10.1055/s-2003-39373. Klin Padiatr. 2003. PMID: 12778354 Clinical Trial. German.

6

Preliminary results of the multicenter trial GPOH-HD 95 for the treatment of Hodgkin's disease in children and adolescents: analysis and outlook.

Dörffel W, Lüders H, Rühl U, Albrecht M, Marciniak H, Parwaresch R, Pötter R, Schellong G, Schwarze EW, Wickmann L. Dörffel W, et al. Klin Padiatr. 2003 May-Jun;215(3):139-45. doi: 10.1055/s-2003-39372. Klin Padiatr. 2003. PMID: 12838937 Clinical Trial.

7

Pediatric Nodular Lymphocyte-predominant Hodgkin Lymphoma: Treatment Recommendations of the GPOH-HD Study Group.

Mauz-Körholz C, Lange T, Hasenclever D, Burkhardt B, Feller AC, Dörffel W, Kluge R, Vordermark D, Körholz D. Mauz-Körholz C, et al. Among authors: dorffel w. Klin Padiatr. 2015 Nov;227(6-7):314-21. doi: 10.1055/s-0035-1559664. Epub 2015 Sep 10. Klin Padiatr. 2015. PMID: 26356319 Review.

8

Salvage therapy of progressive and recurrent Hodgkin's disease: results from a multicenter study of the pediatric DAL/GPOH-HD study group.

Schellong G, Dörffel W, Claviez A, Körholz D, Mann G, Scheel-Walter HG, Bökkerink JP, Riepenhausen M, Lüders H, Pötter R, Rühl U; DAL/GPOH. Schellong G, et al. Among authors: dorffel w. J Clin Oncol. 2005 Sep 1;23(25):6181-9. doi: 10.1200/JCO.2005.07.930. J Clin Oncol. 2005. PMID: 16135485

9

The impact of central review and central therapy planning on the treatment of children and adolescents with Hodgkin lymphoma.

Lüders H, Rühl U, Marciniak H, Haerting J, Claviez A, Mann G, Schellong G, Wickmann L, Dörffel W. Lüders H, et al. Among authors: dorffel w. Eur J Cancer. 2014 Jan;50(2):425-33. doi: 10.1016/j.ejca.2013.09.017. Epub 2013 Oct 21. Eur J Cancer. 2014. PMID: 24157256

10

Immunodeficiency and Hodgkin's disease: treatment and outcome in the DAL HD78-90 and GPOH HD95 studies.

Niehues T, Schellong G, Dörffel W, Bucsky P, Mann G, Körholz D, Göbel U. Niehues T, et al. Among authors: dorffel w. Klin Padiatr. 2003 Nov-Dec;215(6):315-20. doi: 10.1055/s-2003-45498. Klin Padiatr. 2003. PMID: 14677095

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

92 results

Search Page